FACULTAD DE ODONTOLOGÍA
FACULTY
Hospital Severo Ochoa
Madrid, EspañaPublications in collaboration with researchers from Hospital Severo Ochoa (1)
2020
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4